experimental group:Sancailianmei Particle and standard treatment

2 trials

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine

Conditions

Type 2 diabetes combined with nonalcoholic fatty liver disease

Early Phase 1

Efficacy and safety of the Sancailianmei Particle in patients with type 2 diabetes and nonalcoholic fatty liver disease: an open-label, randomised controlled trial

RecruitingITMCTR2000003318

Hospital of Chengdu University of Traditional Chinese MedicineType 2 diabetes combined with nonalcoholic fatty liver disease

Start: 2020-05-16Updated: 2023-02-20

Efficacy and safety of the Sancailianmei Particle in patients with type 2 diabetes and nonalcoholic fatty liver disease: an open-label, randomised controlled trial

RecruitingChiCTR2000033099

Hospital of Chengdu University of Traditional Chinese MedicineType 2 diabetes combined with nonalcoholic fatty liver disease

Start: 2020-05-16Updated: 2020-05-25

Related Papers

Effects of Sancai Lianmei Granules in type 2 diabetes patients with metabolic dysfunction-associated fatty liver disease: a randomized prospective open-label controlled trial.

2025-12-24